Cargando…

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Moharram, Sausan A., Shah, Kinjal, Khanum, Fatima, Rönnstrand, Lars, Kazi, Julhash U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333797/ https://www.ncbi.nlm.nih.gov/pubmed/30647405 http://dx.doi.org/10.1038/s41408-018-0169-1

Ejemplares similares

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

T-cell Acute Lymphoblastic Leukemia Cells Display Activation of Different Survival Pathways
por: Moharram, Sausan A., et al.
Publicado: (2017)

Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
por: Shah, Kinjal, et al.
Publicado: (2018)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
por: Kazi, Julhash U., et al.
Publicado: (2017)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis
por: Wang, Yongfeng, et al.
Publicado: (2016)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
por: Chougule, Rohit A., et al.
Publicado: (2016)

Expression of GADS enhances FLT3-induced mitogenic signaling
por: Chougule, Rohit A., et al.
Publicado: (2016)

Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
por: Moharram, Sausan A., et al.
Publicado: (2016)

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
por: Shah, Kinjal, et al.
Publicado: (2021)

Combination of AZD3463 and DZNep Prevents Bone Metastasis of Breast Cancer by Suppressing Akt Signaling
por: He, Wenxin, et al.
Publicado: (2021)

BEX1 acts as a tumor suppressor in acute myeloid leukemia
por: Lindblad, Oscar, et al.
Publicado: (2015)

Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2017)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
por: Nasimian, Ahmad, et al.
Publicado: (2023)

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
por: Shah, Kinjal, et al.
Publicado: (2022)

Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2023)

AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway
por: Hu, Guang-Fu, et al.
Publicado: (2020)

Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia
por: Sun, Jie, et al.
Publicado: (2016)

T cell receptor (TCR) signaling in health and disease
por: Shah, Kinjal, et al.
Publicado: (2021)

3463 Frontal Alpha Asymmetry in Alcohol-Related Intimate Partner Violence
por: Fink, Brandi C
Publicado: (2019)

P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K
por: Falqués-Costa, Ton, et al.
Publicado: (2023)

Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
por: Shah, Kinjal, et al.
Publicado: (2023)

Letter to the Editor: Detection of EML4-ALK and Other ALK Fusion Genes in Lung Cancer: A Lesson from the Leukemia Fusion Gene Analysis and Future Application
por: Park, Tae Sung, et al.
Publicado: (2012)

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016)

AZD9291-induced Acute Interstitial Lung Disease
por: Nie, Ke-Ke, et al.
Publicado: (2016)

Acute Myeloid Leukemia Masquerading as Acute Appendicitis
por: Shen, Kai, et al.
Publicado: (2017)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Integrative molecular subtypes of acute myeloid leukemia
por: Mo, Qianxing, et al.
Publicado: (2023)

Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation
por: Ricci, Federica, et al.
Publicado: (2020)

Mycobacterium tuberculosis Rv3463 induces mycobactericidal activity in macrophages by enhancing phagolysosomal fusion and exhibits therapeutic potential
por: Park, Hye-Soo, et al.
Publicado: (2019)

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)

Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020)

Orthodontic treatment for a patient with acute myeloid leukemia
por: Hsin-Chung Cheng, Johnson, et al.
Publicado: (2022)

Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
por: Al-Kali, Aref, et al.
Publicado: (2023)

Sorafenib-Induced Eruptive Melanocytic Lesions
por: Chen, Hui-Chun, et al.
Publicado: (2021)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9u209lpeu0gei8fdro3og2msbg